Volume 10, Number 6—June 2004
Research
Quinolone-resistant Campylobacter Infections in Denmark: Risk Factors and Clinical Consequences1
Jørgen Engberg*†
, Jakob Neimann‡, Eva Møller Nielsen§2, Frank Møller Aarestrup§, and Vivian Fussing*3
, Jakob Neimann‡, Eva Møller Nielsen§2, Frank Møller Aarestrup§, and Vivian Fussing*3
Table 4
Number of Campylobacter jejuni subtypes by quinolone susceptibility from domestically acquired infections, retail food products, and broiler chickens
| Origin | Total no. subtypes | Quinolone-resistant (%) | Quinolone-sensitive (%) | Quinolone-resistant and quinolone-sensitive (%) |
|---|---|---|---|---|
| Humans (n = 496)a |
133 |
18 (13.5) |
102 (76.7) |
13 (9.8) |
| Retail food products (n = 172)a |
81 |
9 (11.1) |
70 (86.4) |
2 (2.5) |
| Broiler chickens
(n = 46)a |
20 |
2 (10.0) |
18 (90.0) |
0 (-) |
| 234 | 29 (12.4) | 190 (81.2) | 15 (6.4) |
aTen, 8, and 3 isolates from humans, retail food products, and broiler chickens, respectively, were not tested or nontypeable.
1This study was presented in part at the 12th International Workshop on Campylobacter, Helicobacter and Related Organisms, September 6–10, 2003, Aarhus, Denmark.
2Current affiliation is Statens Serum Institut, Copenhagen, Denmark.
3Current affiliation is Danish Toxicology Centre, Hørsholm, Denmark.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.